Achieve Life Sciences Ownership | Who Owns Achieve Life Sciences?
Achieve Life Sciences Ownership Summary
Achieve Life Sciences is owned by 52.17% institutional investors, 4.37% insiders, and 43.46% retail investors. Franklin resources is the largest institutional shareholder, holding 12.60% of ACHV shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.62% of its assets in Achieve Life Sciences shares.
ACHV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Achieve Life Sciences | 52.17% | 4.37% | 43.46% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Franklin resources | 4.37M | 12.60% | $21.71M |
| Propel bio management | 3.79M | 10.92% | $18.82M |
| Vanguard group | 2.47M | 7.13% | $12.30M |
| Simplify asset management | 1.18M | 3.42% | $5.89M |
| Marshall wace, llp | 774.85K | 2.23% | $2.44M |
| Nantahala capital management | 648.88K | 1.87% | $3.22M |
| Lpl financial | 633.15K | 1.83% | $3.15M |
| Geode capital management | 599.61K | 1.73% | $2.98M |
| Raymond james financial | 456.37K | 1.32% | $1.44M |
| Clearline capital lp | 451.22K | 1.30% | $1.42M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Propel bio management | 3.79M | 16.07% | $18.82M |
| Nantahala capital management | 648.88K | 0.11% | $3.22M |
| Simplify asset management | 1.18M | 0.10% | $5.89M |
| Members wealth | 30.00K | 0.10% | $152.70K |
| Shay capital | 289.55K | 0.08% | $912.07K |
| Clearline capital lp | 451.22K | 0.07% | $1.42M |
| Manchester financial | 59.08K | 0.05% | $293.65K |
| Madison park capital advisors | 10.00K | 0.04% | $49.70K |
| Next capital management | 16.13K | 0.03% | $80.17K |
| Windsor capital management | 10.82K | 0.01% | $53.76K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | 4.37M | 0.01% | 4.35M |
| Marshall wace, llp | 774.85K | 0.00% | 774.85K |
| Two sigma investments, lp | 439.06K | 0.00% | 439.06K |
| Jane street group | 382.21K | 0.00% | 382.21K |
| Squarepoint ops | 373.08K | 0.00% | 359.64K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sofinnova investments | - | - | -1.31M |
| Hudson bay capital management lp | - | - | -1.17M |
| Heights capital management | - | - | -989.51K |
| Clearline capital lp | 451.22K | 0.07% | -875.04K |
| Stonepine capital management | - | - | -333.33K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 774.85K | 0.00% | 774.85K | $2.44M |
| Two sigma investments, lp | 439.06K | 0.00% | 439.06K | $1.38M |
| Two sigma advisers, lp | 110.30K | 0.00% | 110.30K | $347.44K |
| Cubist systematic strategies | 35.52K | 0.00% | 35.52K | $111.90K |
| Citigroup | 32.97K | 0.00% | 32.97K | $163.85K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -8.00 |
| True wealth design | -11.00 |
| Eversource wealth advisors | -26.00 |
| Nisa investment advisors | -52.00 |
| Skopos labs | -210.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 48 | -33.33% | 18,095,323 | 16.43% | 52 | 2.60% | 27 | -37.21% | 7 | -58.82% |
| Sep 30, 2025 | 68 | 9.68% | 15,330,039 | -41.09% | 44 | 0.79% | 42 | 10.53% | 16 | 23.08% |
| Jun 30, 2025 | 67 | -9.46% | 26,224,579 | 82.26% | 75 | 4.39% | 40 | 42.86% | 15 | -34.78% |
| Mar 31, 2025 | 4 | -94.52% | 3,417,252 | -79.09% | 9 | 0.38% | 3 | -91.89% | - | -100.00% |
| Dec 31, 2024 | 73 | 7.35% | 16,339,148 | -3.49% | 50 | 2.10% | 37 | 19.35% | 12 | -14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 2.79M | 5.62% | - |
| Franklin Biotechnology Discovery A | 1.58M | 3.17% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.57M | 3.15% | 41.33K |
| Vanguard US Total Market Shares ETF | 1.03M | 2.96% | - |
| Simplify Propel Opportunities ETF | 1.18M | 2.38% | - |
| iShares Russell 2000 ETF | 800.81K | 2.31% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 567.34K | 1.14% | 11.40K |
| Fidelity Small Cap Index | 346.45K | 0.70% | - |
| Fidelity Extended Market Index | 282.77K | 0.57% | 11.76K |
| iShares Russell 2000 Growth ETF | 177.28K | 0.51% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 18, 2025 | Oki Mark K | Chief Financial Officer | Sell | $146.18K |
| Sep 18, 2025 | Stewart Richard Alistair | Chief Executive Officer | Sell | $378.14K |
| Sep 04, 2025 | Wan Jerry | Principal Accounting Officer | Sell | $38.97K |
| Sep 04, 2025 | KING THOMAS BRAXTON | - | Sell | $387.41K |
| Sep 04, 2025 | JACOBS CINDY | President & CMO | Sell | $76.53K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | - |
| 2025 Q1 | 2 | - |
ACHV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools